
News|Articles|August 21, 2006
New product newswire: August 21, 2006
AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol. The new inhaler is indicated for long-term maintenance treatment of asthma in patients 12 years of age and older.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
CDC Will Focus on BA.2.3 COVID-19 Variant for Upcoming Respiratory Season
2
Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides
3
Executive Order Calls for Realignment of Childhood Vaccines
4
Pneumococcal Disease is Rebounding, Requiring Broader Vaccine Distribution
5






















































